Drugs / Adsorbed Diphtheria-Tetanus Combined Toxoid
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT02118961 Comparator | Apr → Aug 2014 | diphtheria, pertussis, tetanus | Tanabe Pharma Corporation | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Adsorbed Diphtheria-Tetanus Combined Toxoid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02118961 ↗ |
| Known as | DT toxoid | “Adsorbed Diphtheria-Tetanus Combined Toxoid (DT toxoid)” NCT02118961 ↗ |
| Route | Subcutaneous | “subcutaneous injection” NCT02118961 ↗ |